Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais
NCT ID: NCT01115595
Last Updated: 2019-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
84 participants
INTERVENTIONAL
2010-03-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* symptoms score
* medication score
* quality of life
* immunologic test from blood
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
NCT02000648
Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis
NCT05922176
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
NCT00599872
Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination
NCT05009134
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* 2 months
* 6 months
* 12 months
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
injection by Mite extract with standard allergic medication (oral antihistamine and/or topical nasal steroid)
Intervention
Dermatophagoides pteronyssinus from ALK company
Control Group
Injection by buffer solution WITH standard allergic medication (oral antihistamine and/or topical nasal steroid
Control
Injection by buffer solution WITH standard allergic medication (oral antihistamine and/or topical nasal steroid)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
Dermatophagoides pteronyssinus from ALK company
Control
Injection by buffer solution WITH standard allergic medication (oral antihistamine and/or topical nasal steroid)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* positive skin prick test to D.p. at 4+ degree
Exclusion Criteria
* force expiratory volume (FEV1) less than 70% of predicted value
* previous injection immunotherapy within 2 years
* pregnancy
* medical conditions such as ischemic heart disease, autoimmune disease, cancer, previous history of anaphylaxis
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Research Council of Thailand
OTHER_GOV
Pongsakorn Tantilipikorn
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pongsakorn Tantilipikorn
Associate Professor Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pongsakorn Tantilipikorn, M.D.
Role: PRINCIPAL_INVESTIGATOR
Division of allergy and rhinology, Faculty of Medicine Siriraj, Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Allergy and Rhinology, Faculty of Medicine Siriraj, Mahidol University
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
336/2552
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.